
Soltego
SOLTÉGO: A biopharmaceutical innovator leveraging skin pigmentation for therapeutic and aesthetic applications.

SOLTÉGO: A biopharmaceutical innovator leveraging skin pigmentation for therapeutic and aesthetic applications.
Founded by experts in dermatology and oncology, Soltego is a biopharmaceutical innovator focused on leveraging skin pigmentation for therapeutic and aesthetic applications. The company's core mission is to harness the biological power of skin pigmentation to develop transformative solutions that protect and enhance skin health. Soltego's product offerings are designed to address both medical and cosmetic needs, targeting a market that spans healthcare providers, dermatologists, and consumers seeking advanced skin care solutions.
Notable figures affiliated with Soltego include leading scientists and medical professionals in the fields of dermatology and oncology. The company has attracted significant interest from investors in the biopharmaceutical sector, underscoring its potential for impactful innovation. Key achievements include pioneering research into skin biology and the development of novel therapies that have garnered attention in both scientific and consumer communities. Overall, Soltego's work promises to make substantial contributions to skin health and aesthetics, positioning it as a leader in its niche market.
Companies similar to Soltego include Thesan Pharmaceuticals, DermBiont, Vilacto Bio and TBT Pharma.
Soltego was founded in 2017.
Soltego's headquarters is located in Newport Beach, CA, US.
Soltego's most recent funding round was for $6.7M (USD) in April 2019.
As of Apr 22, 2019, Soltego has disclosed funding of $6.7M (USD). Undisclosed round amounts are excluded.
Soltego has 9 employees as of Feb 5, 2024.

TBT Pharma
tbtpharma.com